T0	Participants 129 186	children being treated for acute lymphoblastic leukaemia.
T1	Participants 374 485	Children were investigated who were receiving glucocorticoid treatment for acute lymphoblastic leukaemia (ALL).
T2	Participants 862 870	children
T3	Participants 1006 1123	Nineteen children (8 male, 11 female) with a median age 5.9 years (range 2.6-13 years) were recruited into the study.